The Valley Desk

NCT00779480 · Interventional trial

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)

Overall registry status Terminated

Phase 1

Conditions Acute Myelogenous Leukemia (AML)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov